Open AccessMutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group
Author(s) -
Silvia Bresolin,
Paola De Filippi,
Francesca Vendemini,
Mirko D’Alia,
Marco Zecca,
Lueder Hinrich Meyer,
Cesare Danesino,
Franco Locatelli,
Riccardo Masetti,
Giuseppe Basso,
Geertruy te Kronnie
Publication year - 2016
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.8016
Subject(s) - juvenile myelomonocytic leukemia , cancer research , medicine , leukemia , mutation , oncology , immunology , biology , stem cell , gene , genetics , haematopoiesis
Juvenile myelomonocytic leukemia (JMML) is a rare aggressive disease of early childhood. Driver mutations in the Ras signaling pathways are a key feature of JMML patients. Mutations in SETBP1 and JAK3 were recently identified in a subset of JMML patients characterized by poor prognosis and progression of disease. In this study, we report the results of a screening for mutations in SETBP1 and JAK3 of a cohort of seventy Italian patients with JMML, identifying 11.4% of them harboring secondary mutations in these two genes and discovering two new mutations in the SKI domain of SETBP1.JMML xenotransplantation and colony assay provide an initial understanding of the secondary nature of these events occurring in early precursor cells and suggest a different propagating capacity of clones harboring particular mutations.